Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jun 2:25:86-88.
doi: 10.1016/j.jdcr.2022.05.022. eCollection 2022 Jul.

The use of montelukast for pruritus in neurofibromatosis 1

Nicole L Edmonds  1   2 , Lydia A Luu  2 , Darren J Guffey  2
Affiliations
Case Reports

The use of montelukast for pruritus in neurofibromatosis 1

Nicole L Edmonds et al. JAAD Case Rep. .
No abstract available

Keywords: NF1; NF1, neurofibromatosis 1; RTK, receptor tyrosine kinases; general dermatology; mast cell; medical dermatology; montelukast; neurofibroma; neurofibromatosis; pheochromocytoma; sunitinib.

PubMed Disclaimer

Conflict of interest statement

None disclosed.

Figures

Fig 1
Fig 1
Pink, inflamed neurofibromas narrowly surrounded by small, pink plaques were observed, most notably on the upper back before therapy with montelukast (A). A significant reduction in neurofibroma inflammation was observed after therapy with montelukast (B).
See this image and copyright information in PMC

References

    1. Ferner R.E. Neurofibromatosis 1. Eur J Hum Genet. 2007;15(2):131–138. doi: 10.1038/sj.ejhg.5201676. - DOI - PubMed
    1. Hari Kumar K.V., Shaikh A., Sandhu A.S., Prusty P. Neurofibromatosis 1 with pheochromocytoma. Indian J Endocrinol Metab. 2011;15(suppl 4):S406–S408. doi: 10.4103/2230-8210.86988. - DOI - PMC - PubMed
    1. Ferguson M.J., Rhodes S.D., Jiang L., et al. Preclinical evidence for the use of sunitinib malate in the treatment of plexiform neurofibromas. Pediatr Blood Cancer. 2016;63(2):206–213. doi: 10.1002/pbc.25763. - DOI - PMC - PubMed
    1. Baudin E., Goichot B., Berruti A., et al. 567O First international randomized study in malignant progressive pheochromocytoma and paragangliomas (FIRSTMAPPP): an academic double-blind trial investigating sunitinib. Ann Oncol. 2021;32(suppl 5):S621–S625. doi: 10.1016/annonc/annonc700. - DOI
    1. Ara M., Pastushenko E. Antiangiogenic agents and the skin: cutaneous adverse effects of sorafenib, sunitinib, and bevacizumab. Actas Dermosifiliogr. 2014;105(10):900–912. doi: 10.1016/j.ad.2014.02.010. Article in English, Spanish. - DOI - PubMed

Publication types